Free Trial
NASDAQ:HROW

Harrow (HROW) Stock Price, News & Analysis

Harrow logo
$38.96 +0.17 (+0.43%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Harrow Stock (NASDAQ:HROW)

Key Stats

Today's Range
$38.68
$39.70
50-Day Range
$30.54
$40.01
52-Week Range
$20.85
$59.23
Volume
233,797 shs
Average Volume
482,243 shs
Market Capitalization
$1.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.67
Consensus Rating
Buy

Company Overview

Harrow Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

HROW MarketRank™: 

Harrow scored higher than 69% of companies evaluated by MarketBeat, and ranked 313th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Harrow has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Harrow has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Harrow's stock forecast and price target.
  • Earnings Growth

    Earnings for Harrow are expected to grow in the coming year, from ($0.53) to $0.40 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Harrow is -156.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Harrow is -156.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Harrow has a P/B Ratio of 29.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Harrow's valuation and earnings.
  • Percentage of Shares Shorted

    14.46% of the float of Harrow has been sold short.
  • Short Interest Ratio / Days to Cover

    Harrow has a short interest ratio ("days to cover") of 9.7.
  • Change versus previous month

    Short interest in Harrow has recently increased by 8.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Harrow does not currently pay a dividend.

  • Dividend Growth

    Harrow does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.46% of the float of Harrow has been sold short.
  • Short Interest Ratio / Days to Cover

    Harrow has a short interest ratio ("days to cover") of 9.7.
  • Change versus previous month

    Short interest in Harrow has recently increased by 8.43%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Harrow has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Harrow this week, compared to 6 articles on an average week.
  • Search Interest

    9 people have searched for HROW on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added Harrow to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Harrow insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.16% of the stock of Harrow is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    72.76% of the stock of Harrow is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Harrow's insider trading history.
Receive HROW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harrow and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HROW Stock News Headlines

Harrow: Few Hits Carrying Misses (Rating Downgrade)
Harrow, Inc. (HROW): A Bull Case Theory
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Harrow, Inc. (HROW): A Bull Case Theory
Harrow Health Appoints New President and CFO
B. Riley Has Positive Estimate for Harrow Q3 Earnings
HC Wainwright Has Bullish Outlook for Harrow FY2025 Earnings
See More Headlines

HROW Stock Analysis - Frequently Asked Questions

Harrow's stock was trading at $33.55 at the start of the year. Since then, HROW stock has increased by 16.9% and is now trading at $39.2150.

Harrow, Inc. (NASDAQ:HROW) posted its earnings results on Monday, August, 11th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.23. The business had revenue of $63.74 million for the quarter, compared to analysts' expectations of $64.23 million. Harrow had a negative trailing twelve-month return on equity of 2.18% and a negative net margin of 4.49%.
Read the conference call transcript
.

Top institutional shareholders of Harrow include Opaleye Management Inc. (10.55%), Braidwell LP (2.36%), Geode Capital Management LLC (2.21%) and Marshall Wace LLP (1.54%). Insiders that own company stock include Opaleye Management Inc, Mark L Baum, Andrew R Boll, Martin A Makary, Richard L Md Lindstrom and Horn R Lawrence Van.
View institutional ownership trends
.

Shares of HROW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Harrow investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Visa (V), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/11/2025
Today
8/28/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HROW
Previous Symbol
NASDAQ:HROW
CIK
1360214
Employees
180
Year Founded
N/A

Price Target and Rating

High Price Target
$76.00
Low Price Target
$55.00
Potential Upside/Downside
+66.3%
Consensus Rating
Buy
Rating Score (0-4)
3.13
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.48 million
Net Margins
-4.49%
Pretax Margin
-4.71%
Return on Equity
-2.18%
Return on Assets
-0.35%

Debt

Debt-to-Equity Ratio
0.78
Current Ratio
0.62
Quick Ratio
0.58

Sales & Book Value

Annual Sales
$199.61 million
Price / Sales
7.21
Cash Flow
$0.14 per share
Price / Cash Flow
282.07
Book Value
$1.33 per share
Price / Book
29.24

Miscellaneous

Outstanding Shares
37,000,000
Free Float
31,392,000
Market Cap
$1.44 billion
Optionable
Optionable
Beta
0.41

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:HROW) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners